5 research outputs found
MYD88 L265P mutation in primary central nervous system lymphoma is associated with better survival:A single-center experience
Kinomics platform using GBM tissue identifies BTK as being associated with higher patient survival
Synaptome mapping of the postsynaptic density 95 protein in the human brain
The past three decades of synaptic research have provided new insights into synapse
biology. While synapses are still considered the fundamental connectors between
the nerve cells in the central nervous system, they are no longer seen as simple
neuron-to-neuron contacts. In fact, the estimated 100 trillion of human synapses are
extremely complex, diverse and capable of performing sophisticated computational
operations giving rise to advanced repertoires of cognitive and organic behaviours.
These intricate synaptic properties mean that existing methodologies for
quantifying and characterising synapses are inadequate. Yet, understanding of synapse
biology is crucial to deciphering human pathology as disruptions in synapse numbers,
architecture and function have already been linked to many human brain disorders.
The purpose of this PhD was to evaluate a novel, high-throughput synaptic
protein quantification method at a single synapse resolution in human post-mortem
brain tissue. The method has already been successfully tested in our laboratory in
genetically engineered mice, whereby synapses have been systematically quantified
across a large number of areas to generate the first molecular maps of synapses, the
synaptome maps.
In this project, methods have been developed to label human brain tissue with
postsynaptic density protein 95 (PSD-95), the most common postsynaptic protein. We
describe the use of PSD-95 combined with confocal microscopy and computational
image analysis to quantify synaptic puncta immunofluorescence (IF) parameters in
the human brain. In the first part of this study, the new method was used to
quantify PSD-95 IF across selected 20 human brain regions to generate first PSD-95
human synaptome map. In the second part, PSD-95 IF was systematically assessed
across 16 hippocampal subregions. Finally, we confirmed that our novel synaptic
quantification method was sensitive to hippocampal synaptic losses in patients with
Alzheimer’s Disease (AD). Such a high degree of systematic synapse quantification
has not previously been reported in human brain tissue.
Our method is a promising approach for synaptic protein quantification in tissue
with several potential applications in diagnosis and development of therapeutics for
neurological and psychiatric disorders